Oral immunotherapy for the treatment of peanut allergy: Is it ready for prime time?

TY - JOUR

T1 - Oral immunotherapy for the treatment of peanut allergy

T2 - Is it ready for prime time?

AU - Wood, Robert A.

AU - Sampson, Hugh A.

N1 - Funding Information: Conflicts of interest: R. A. Wood has received consultancy fees from the Asthma and Allergy Foundation of America; is employed by Johns Hopkins University; has received research support from the National Institutes of Health (NIH) ; and receives royalties from UpToDate. H. A. Sampson has received research support from the National Institute of Allergy and Infectious Diseases , NIH (Consortium of Food Allergy Research); has received funding supporting clinical trials in milk and wheat allergy from the Food Allergy Research Education ; has received travel support as chair of PhARF Award Review Committee; has received consultancy fees from Allertein Therapeutics and Regeneron; has received lecture fees from ThermoFisher Scientific, UCB, and Pfizer.

PY - 2014/1

Y1 - 2014/1

UR - http://www.scopus.com/inward/record.url?scp=84891643431&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84891643431&partnerID=8YFLogxK

U2 - 10.1016/j.jaip.2013.11.010

DO - 10.1016/j.jaip.2013.11.010

M3 - Editorial

C2 - 24565776

AN - SCOPUS:84891643431

SN - 2213-2198

VL - 2

SP - 97

EP - 98

JO - Journal of Allergy and Clinical Immunology: In Practice

JF - Journal of Allergy and Clinical Immunology: In Practice

IS - 1

ER -